09:52 AM EST - Microbix Biosystems Inc. : Announces that it has commercialized custom biological materials for incorporation into the lab-based assays or point-of-care test-cartridges of in-vitro diagnostics manufacturers. Initial sales have been made to two DxMs, each of which is incorporating a Microbix biologic material into a new assay or assays. Microbix Biosystems Inc.
shares T.MBX are trading unchanged at $0.28.